227 related articles for article (PubMed ID: 1869274)
1. High-dose chemotherapy and autologous bone marrow support for breast cancer.
Peters WP
Important Adv Oncol; 1991; ():135-50. PubMed ID: 1869274
[No Abstract] [Full Text] [Related]
2. [Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer].
Rühl U
Strahlenther Onkol; 2000 Apr; 176(4):196-7. PubMed ID: 10812394
[No Abstract] [Full Text] [Related]
3. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
Smith GA; Henderson IC
Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
[No Abstract] [Full Text] [Related]
4. Dose intensity studies in breast cancer--autologous bone marrow transplantation.
Hortobagyi GN; Dunphy F; Buzdar AU; Spitzer G
Prog Clin Biol Res; 1990; 354B():195-209. PubMed ID: 2236166
[No Abstract] [Full Text] [Related]
5. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.
Peters WP
Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808
[No Abstract] [Full Text] [Related]
6. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
Maraninchi D; Droz JP
Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
[TBL] [Abstract][Full Text] [Related]
7. [High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].
Nielsen DL; Svane IM
Ugeskr Laeger; 2004 Nov; 166(46):4148-50. PubMed ID: 15565849
[No Abstract] [Full Text] [Related]
8. Current legal intervention regarding "experimental" treatments must be changed: an analysis of high doses of chemotherapy with autologous bone marrow transplantation for breast cancer patients.
Smayda E
J Law Health; 1998-1999; 13(2):257-80. PubMed ID: 10947396
[No Abstract] [Full Text] [Related]
9. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
[TBL] [Abstract][Full Text] [Related]
10. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.
Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S
Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487
[TBL] [Abstract][Full Text] [Related]
11. End of high-dose chemotherapy for high-risk breast cancer patients?
Tuma RS
J Natl Cancer Inst; 2008 May; 100(9):618-9. PubMed ID: 18445811
[No Abstract] [Full Text] [Related]
12. [High-dose chemotherapy with hematopoietic salvage in patients with breast cancer].
Perey L; Leyvraz S
Praxis (Bern 1994); 1995 Mar; 84(9):259-63. PubMed ID: 7892554
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.
Tannir N; Spitzer G; Schell F; Legha S; Zander A; Blumenschein G
Cancer Treat Rep; 1983 Jun; 67(6):599-600. PubMed ID: 6344995
[No Abstract] [Full Text] [Related]
14. The role of high-dose chemotherapy with autologous bone marrow transplantation in the treatment of breast cancer.
Hortobagyi GN
Bone Marrow Transplant; 1988 Nov; 3(6):525-30. PubMed ID: 3063320
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy with autologous stem cell support for breast cancer.
Meropol NJ; Overmoyer BA; Stadtmauer EA
Oncology (Williston Park); 1992 Dec; 6(12):53-60, 63; discussion 63-4, 69. PubMed ID: 1467164
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of colony growth and hematologic engraftment in patients undergoing high-dose chemotherapy and autologous bone marrow transplantation for breast cancer.
Meehan KR; Ericson SG; Tosteson TD; Mills LE
Prog Clin Biol Res; 1994; 389():497-503. PubMed ID: 7535459
[No Abstract] [Full Text] [Related]
17. [High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review].
Nielsen DL; Svane IM
Ugeskr Laeger; 2004 Nov; 166(46):4145-7. PubMed ID: 15565848
[No Abstract] [Full Text] [Related]
18. Dose intensification using combination alkylating agents and autologous bone marrow support in the treatment of primary and metastatic breast cancer: a review of the Duke Bone Marrow Transplantation Program experience.
Peters WP
Prog Clin Biol Res; 1990; 354B():185-94. PubMed ID: 2236164
[No Abstract] [Full Text] [Related]
19. Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy.
Vredenburgh JJ; Peters WP; Rosner G; DeSombre K; Johnston WW; Kamel A; Wu K; Bast RC
Bone Marrow Transplant; 1995 Dec; 16(6):815-21. PubMed ID: 8750275
[TBL] [Abstract][Full Text] [Related]
20. The role of high-dose chemotherapy with autologous bone marrow support in breast cancer: state of the art.
Sulkes A
Isr J Med Sci; 1993; 29(2-3):111-6. PubMed ID: 8468162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
